About Scil Proteins
Scil Proteins is a company based in Halle (Germany) founded in 1999 was acquired by Wacker Chemie in June 2014.. Scil Proteins has raised $32.07 million across 1 funding round from investors including Wacker Chemie and BioNet Pharma. The company has 54 employees as of December 31, 2021. Scil Proteins operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Halle, Germany
- Employees 54 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Navigo Proteins Gmbh
-
Annual Revenue
$56.91 K (USD)2as on Dec 31, 2015
-
Net Profit
$-3.93 M (USD)-16as on Dec 31, 2015
-
EBITDA
-
Total Equity Funding
$32.07 M (USD)
in 1 rounds
-
Latest Funding Round
$32.07 M (USD), Series C
Jun 01, 2010
-
Investors
Wacker Chemie
& 1 more
-
Employee Count
54
as on Dec 31, 2021
-
Acquired by
Wacker Chemie
(Jun 01, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Scil Proteins
Scil Proteins has successfully raised a total of $32.07M through 1 strategic funding round. The most recent funding activity was a Series C round of $32.07 million completed in June 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $32.1M
-
First Round
First Round
(01 Jun 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2010 | Amount | Series C - Scil Proteins | Valuation | BioNet Pharma |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Scil Proteins
Scil Proteins has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Wacker Chemie and BioNet Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Develops and licenses pharmaceutical programs for various indications through partnerships.
|
Founded Year | Domain | Location | |
|
Silicones, polymers, and bio-solutions are manufactured for various industries.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Scil Proteins
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Scil Proteins
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Scil Proteins Comparisons
Competitors of Scil Proteins
Scil Proteins operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Scil Proteins
When was Scil Proteins founded?
Scil Proteins was founded in 1999 and raised its 1st funding round 11 years after it was founded.
Where is Scil Proteins located?
Scil Proteins is headquartered in Halle, Germany. It is registered at Halle, Sachsen-anhalt, Germany.
Is Scil Proteins a funded company?
Scil Proteins is a funded company, having raised a total of $32.07M across 1 funding round to date. The company's 1st funding round was a Series C of $32.07M, raised on Jun 01, 2010.
How many employees does Scil Proteins have?
As of Dec 31, 2021, the latest employee count at Scil Proteins is 54.
What is the annual revenue of Scil Proteins?
Annual revenue of Scil Proteins is $56.91K as on Dec 31, 2015.
What does Scil Proteins do?
Scil Proteins was established in 1999 in Halle, Germany, within the biotechnology sector. Affilin-based proteins, derived from human scaffolds, are engineered using a proprietary modular platform for therapeutic and non-therapeutic purposes. Operations focus on developing drug conjugates, multi-specific binding molecules, and ligands for partners in pharmaceuticals, biotech, and life sciences. Full ownership is maintained by BioNet Ventures.
Who are the top competitors of Scil Proteins?
Scil Proteins's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Scil Proteins's investors?
Scil Proteins has 2 investors. Key investors include Wacker Chemie, and BioNet Pharma.